Good morning :)
Place Order
Add to Watchlist

Parnax Lab Ltd

PARNAXLAB Share Price

108.000.51% (+0.55)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹123 cr, stock is ranked 2,868

Stock is 4.02x as volatile as Nifty

PARNAXLAB Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹123 cr, stock is ranked 2,868

Stock is 4.02x as volatile as Nifty

PARNAXLAB Performance & Key Metrics

PARNAXLAB Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
10.781.73
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.216.660.83%

PARNAXLAB Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

PARNAXLAB Company Profile

Parnax Lab is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations

PARNAXLAB Similar Stocks (Peers)

Compare with peers Compare with peers 

PARNAXLAB Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
87.88
87.88
PE Ratio
23.03
23.03
1Y Return
2.38%
2.38%
Buy Reco %
74.19
74.19
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
56.67
56.67
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
72.00
72.00
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
81.25
81.25
Compare with Peers

PARNAXLAB Forecast

PARNAXLAB Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

PARNAXLAB

PARNAXLAB

Income

Balance Sheet

Cash Flow

PARNAXLAB Income Statement

PARNAXLAB Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 11.32%, vs industry avg of 9.02%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.05%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 23.83%, vs industry avg of 15.29%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue95.18106.69110.8995.9790.27163.36168.38189.53189.41189.41
Raw Materialssubtract58.0262.2359.9354.4348.49101.47101.31118.31160.97160.97
Power & Fuel Costsubtract3.272.993.134.124.295.245.376.37
Employee Costsubtract9.2211.6813.0614.0813.6817.4320.0523.72
Selling & Administrative Expensessubtract4.498.0912.366.744.866.758.338.54
Operating & Other expensessubtract6.7910.6110.089.518.809.119.568.23
Depreciation/Amortizationsubtract3.753.743.824.465.165.876.536.967.387.39
Interest & Other Itemssubtract4.924.323.894.605.085.234.955.355.395.39
Taxes & Other Itemssubtract1.031.971.320.950.284.033.662.444.164.17
EPS4.341.253.88-3.43-0.448.988.098.3710.0510.00
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

PARNAXLAB Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

PARNAXLAB Stock Peers

PARNAXLAB Past Performance & Peer Comparison

PARNAXLAB Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Parnax Lab Ltd10.761.73
Sun Pharmaceutical Industries Ltd37.006.030.95%
Cipla Ltd23.034.531.06%
Dr Reddy's Laboratories Ltd20.024.010.59%

PARNAXLAB Stock Price Comparison

Compare PARNAXLAB with any stock or ETF
Compare PARNAXLAB with any stock or ETF
PARNAXLAB
Loading...

PARNAXLAB Holdings

PARNAXLAB Shareholdings

PARNAXLAB Promoter Holdings Trend

PARNAXLAB Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

PARNAXLAB Institutional Holdings Trend

PARNAXLAB Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

PARNAXLAB Shareholding Pattern

PARNAXLAB Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding72.30%0.00%0.00%0.00%27.70%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

PARNAXLAB Shareholding History

PARNAXLAB Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

PARNAXLAB Insider Trades & Bulk Stock Deals

PARNAXLAB Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing PARNAXLAB stock

smallcases containing PARNAXLAB stock

Looks like this stock is not in any smallcase yet.

PARNAXLAB Events

PARNAXLAB Events

PARNAXLAB Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

PARNAXLAB has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

PARNAXLAB Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

PARNAXLAB has not given any dividends in last 5 years

PARNAXLAB Dividends

PARNAXLAB Dividends

Hmm, looks like data is unavailable here. Please come back after some time

PARNAXLAB Stock News & Opinions

PARNAXLAB Stock News & Opinions

Earnings
Parnax Lab consolidated net profit rises 30.36% in the March 2025 quarter

Net profit of Parnax Lab rose 30.36% to Rs 2.92 crore in the quarter ended March 2025 as against Rs 2.24 crore during the previous quarter ended March 2024. Sales rose 5.76% to Rs 49.04 crore in the quarter ended March 2025 as against Rs 46.37 crore during the previous quarter ended March 2024. For the full year,net profit rose 19.88% to Rs 11.52 crore in the year ended March 2025 as against Rs 9.61 crore during the previous year ended March 2024. Sales declined 0.51% to Rs 187.74 crore in the year ended March 2025 as against Rs 188.71 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales49.0446.37 6 187.74188.71 -1 OPM %13.5212.49 -14.2512.47 - PBDT5.784.63 25 23.0519.01 21 PBT3.952.79 42 15.6712.05 30 NP2.922.24 30 11.529.61 20 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Parnax Lab to discuss results

Parnax Lab will hold a meeting of the Board of Directors of the Company on 27 May 2025.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Parnax Lab consolidated net profit declines 44.50% in the December 2024 quarter

Net profit of Parnax Lab declined 44.50% to Rs 1.21 crore in the quarter ended December 2024 as against Rs 2.18 crore during the previous quarter ended December 2023. Sales declined 21.12% to Rs 40.22 crore in the quarter ended December 2024 as against Rs 50.99 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales40.2250.99 -21 OPM %10.6211.71 - PBDT3.234.72 -32 PBT1.452.94 -51 NP1.212.18 -44 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Parnax Lab to declare Quarterly Results

Parnax Lab will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Parnax Lab consolidated net profit rises 82.35% in the September 2024 quarter

Net profit of Parnax Lab rose 82.35% to Rs 3.41 crore in the quarter ended September 2024 as against Rs 1.87 crore during the previous quarter ended September 2023. Sales rose 13.49% to Rs 48.36 crore in the quarter ended September 2024 as against Rs 42.61 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales48.3642.61 13 OPM %14.9712.41 - PBDT6.814.08 67 PBT4.872.34 108 NP3.411.87 82 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Parnax Lab to convene board meeting

Parnax Lab will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Parnax Lab to conduct AGM

Parnax Lab announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Parnax Lab consolidated net profit rises 19.88% in the June 2024 quarter

Net profit of Parnax Lab rose 19.88% to Rs 3.98 crore in the quarter ended June 2024 as against Rs 3.32 crore during the previous quarter ended June 2023. Sales rose 2.83% to Rs 50.12 crore in the quarter ended June 2024 as against Rs 48.74 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales50.1248.74 3 OPM %17.2013.34 - PBDT7.235.58 30 PBT5.403.98 36 NP3.983.32 20 Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Parnax Lab announces board meeting date

Parnax Lab will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live

Parnax Lab Consolidated March 2023 Net Sales at Rs 40.91 crore, down 14.62% Y-o-Y

1 year agoMoneycontrol

Frequently asked questions

Frequently asked questions

  1. What is the share price of Parnax Lab Ltd (PARNAXLAB) today?

    The share price of PARNAXLAB as on 13th June 2025 is ₹108. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Parnax Lab Ltd (PARNAXLAB) share?

    The past returns of Parnax Lab Ltd (PARNAXLAB) share are
    • Past 1 week: 0.33%
    • Past 1 month: 17.34%
    • Past 3 months: 20.27%
    • Past 6 months: -35.29%
    • Past 1 year: -4.37%
    • Past 3 years: 4.00%
    • Past 5 years: 511.90%

  3. What are the peers or stocks similar to Parnax Lab Ltd (PARNAXLAB)?
  4. What is the market cap of Parnax Lab Ltd (PARNAXLAB) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Parnax Lab Ltd (PARNAXLAB) is ₹123.88 Cr as of 13th June 2025.

  5. What is the 52 week high and low of Parnax Lab Ltd (PARNAXLAB) share?

    The 52-week high of Parnax Lab Ltd (PARNAXLAB) is ₹193.50 and the 52-week low is ₹81.

  6. What is the PE and PB ratio of Parnax Lab Ltd (PARNAXLAB) stock?

    The P/E (price-to-earnings) ratio of Parnax Lab Ltd (PARNAXLAB) is 10.76. The P/B (price-to-book) ratio is 1.73.

  7. Which sector does Parnax Lab Ltd (PARNAXLAB) belong to?

    Parnax Lab Ltd (PARNAXLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Parnax Lab Ltd (PARNAXLAB) shares?

    You can directly buy Parnax Lab Ltd (PARNAXLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.